Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

US Patent 10106553 · Granted Oct 23, 2018

Estimated economic value: $106,668,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lactic acid bacteria and its applications2024
Set membership testers for aligning nucleic acid samples2022
Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors2022
Cyclohexyl GPR40 agonists for the treatment of type II diabetes2021
Cyclohexyl GPR40 agonists for the treatment of type II diabetes2021
Cyclohexyl GPR40 agonists for the treatment of type II diabetes2021
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2020
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2020
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2018
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2018
GPR40 agonists for the treatment of type II diabetes2018
GPR40 agonists for the treatment of type II diabetes2018